$15.99
+1.32 (+9.00%)
Performance
1D
—
1W
—
1M
—
3M
+359.48%
6M
+657.82%
1Y
+980.41%
YTD
+345.40%
Open$14.90
Previous Close$14.67
Day High$16.16
Day Low$14.90
52W High$13.28
52W Low$1.01
Volume—
Avg Volume3.82M
Market Cap3.84B
P/E Ratio—
EPS$-0.45
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$7.48
Above
SMA 200
$3.25
Above
RSI (14)
71.9
Overbought
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
17 analysts
Price Target
+54.2% upside
Current
$15.99
$15.99
Target
$24.65
$24.65
$19.75
$24.65 avg
$31.92
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 897.62M | 918.48M | 827.43M |
| Net Income | -100,463,137 | -95,918,574 | -115,001,691 |
| Profit Margin | -11.2% | -10.4% | -13.9% |
| EBITDA | -104,291,949 | -115,509,109 | -110,721,792 |
| Free Cash Flow | -130,963,293 | -137,514,931 | -125,568,165 |
| Rev Growth | +16.3% | +1.8% | +8.3% |
| Debt/Equity | 0.25 | 0.25 | 0.19 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $207.18 | +0.96% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $353.93 | +1.58% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $138.26 | +0.11% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $454.97 | +1.42% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $749.47 | +1.05% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.70 | +6.70% | 139.7 | 43.84B |